Bos, Isabelle
Vos, Stephanie J.
Frölich, Lutz
Kornhuber, Johannes
Wiltfang, Jens
Maier, Wolfgang
Peters, Oliver
Rüther, Eckhart
Engelborghs, Sebastiaan
Niemantsverdriet, Ellis
De Roeck, Ellen Elisa https://orcid.org/0000-0002-6566-6562
Tsolaki, Magda
Freund-Levi, Yvonne https://orcid.org/0000-0001-6863-6679
Johannsen, Peter
Vandenberghe, Rik
Lleó, Alberto
Alcolea, Daniel
Frisoni, Giovanni B.
Galluzzi, Samantha
Nobili, Flavio
Morbelli, Silvia
Drzezga, Alexander
Didic, Mira
van Berckel, Bart N.
Salmon, Eric
Bastin, Christine
Dauby, Solene
Santana, Isabel
Baldeiras, Inês
de Mendonça, Alexandre
Silva, Dina
Wallin, Anders
Nordlund, Arto
Coloma, Preciosa M.
Wientzek, Angelika
Alexander, Myriam
Novak, Gerald P.
Gordon, Mark Forrest https://orcid.org/0000-0002-0271-3050
Wallin, Åsa K.
Hampel, Harald
Soininen, Hilkka https://orcid.org/0000-0002-2785-9937
Herukka, Sanna-Kaisa
Scheltens, Philip
Verhey, Frans R.
Visser, Pieter Jelle
Funding for this research was provided by:
Innovative Medicines Initiative Joint Undertaking under EMIF (115372)
European Union's Seventh Framework Programme (FP7/2007-2013)
EFPIA companies
European Union Seventh Framework Programme (FP7-ICT-2011-9-601055)
European Union Seventh Framework Programme (601055)
German Federal Ministry of Education and Research (BMBF): Kompetenznetz Demenzen (01GI0420)
Janssen-Cilag
Merz Pharmaceuticals
European Commission within the 5th framework program (QLRT-2001-2455)
European Commission within the 5th framework program (37670)
Fundação para a Ciência e Tecnologia–Portugal (PIC/IC/83206/2007)
Alzheimer Nederland and Stichting VUmc fonds
Stichting Dioraphte
ADNI
National Institutes of Health (U01 AG024904)
DOD ADNI Department of Defense (W81XWH-12-2-0012)
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
BioClinica, Inc
Biogen Idec Inc
Bristol-Myers Squibb Company
Eisai Inc
Elan Pharmaceuticals, Inc
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Genentech, Inc
GE Healthcare
Innogenetics, N.V.
IXICO Ltd.
Janssen Alzheimer Immunotherapy Research & Development, LLC
Johnson & Johnson Pharmaceutical Research & Development LLC
Medpace, Inc
Merck & Co, Inc
Meso Scale Diagnostics, LLC
NeuroRx Research
Novartis Pharmaceuticals Corporation
Pfizer Inc
Piramal Imaging
Servier
Synarc Inc
Takeda Pharmaceutical Company
Canadian Institutes of Health Research
Northern California Institute for Research and Education
This article is maintained by: Elsevier
Article Title: The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
Journal Title: Neurobiology of Aging
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.neurobiolaging.2017.03.034
Content Type: article
Copyright: © 2017 Elsevier Inc. All rights reserved.